RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @CAPUD2016: "...unless oral meds don't work for you, in which case you're fucked." #opioidguideline https://t.co/chHWqoOjqh
Best piece I have seen in awhile. I had to share. https://t.co/bEBPt62aFM
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
"...unless oral meds don't work for you, in which case you're fucked." #opioidguideline https://t.co/chHWqoOjqh
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @maiasz: +1000 https://t.co/DfGIFicnez
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @CrismCan: Canadian guideline to treat #opioid use disorder published today in @CMAJ https://t.co/gSbLI2Ufhw @KeithAhamad @CRCHUM @BCCSU…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
https://t.co/348eiiLHvY too bad "treatment" doesn't work.Too bad INDIVIOR refused to release .3mg taper dose of Suboxone in US.Too bad profit maker treatment center AND INDIVIOR ignored the @YaleMed study to make 24/7 detox & holdover doses of bupe w o
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
If you don't, please start @Royal_College @CMA_Docs @OMSAofficial @OntarioCollege https://t.co/pYuzP9bF1G
RT @maiasz: +1000 https://t.co/DfGIFicnez
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @picardonhealth: New clinical practice guideline on management of #opioids use disorders. https://t.co/Wu1QFXsiJC via @CMAJ https://t.co…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
I love this. https://t.co/hu5IgWarOO
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Thank you for sharing these! https://t.co/trgVHNmIGt
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @CrismCan: LISTEN: Drs. Evan Wood, @KeithAhamad, Julie Bruneau and @DreGoyer on @CMAJ podcasts discussing the new #opioid guideline http…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @maiasz: +1000 https://t.co/DfGIFicnez
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Management of opioid use disorders: a national clinical practice guideline | CMAJ https://t.co/lMPA9GappR
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
New national clinical practice guidelines and recommendations for the treatment of opioid use disorders for Canadian health professionals https://t.co/rZHh8sRvcn
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @RJmdphilly: @PEMammen @TJUHospital @theEDpharmacist @JeffIMchiefs Here’s the link to the full statement. Many recs with strong evidenc…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @maiasz: +1000 https://t.co/DfGIFicnez
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
New clinical practice guideline on management of #opioid use disorders via @CMAJ https://t.co/O6f0kok19d
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @reversechapter: Is this evidence-based research? They should have added more levels of fuzziness. I'd recommend "low-moderate," and "mo…
RT @sanoysalvoblog: Manejo de los trastornos por uso de opioides: nueva guía de práctica clínica, de libre acceso en @CMAJ https://t.co/eAG…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @sanoysalvoblog: Manejo de los trastornos por uso de opioides: nueva guía de práctica clínica, de libre acceso en @CMAJ https://t.co/eAG…
RT @AMehta82: New #CPG on the management of opioid Use disorders. Will greatly help #physicians. #opioiduse @Albertadoctors @UCalgaryFamM…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @picardonhealth: New clinical practice guideline on management of #opioids use disorders. https://t.co/Wu1QFXsiJC via @CMAJ https://t.co…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…